Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Catalent Pharma Expands in China with Two Deals

publication date: Mar 11, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Catalent Pharma Solutions, a New Jersey company, announced two transactions that will increase its presence in China. First, Catalent will acquire majority share of Zhejiang Jiang Yuan Tang Biotechnology Co., a Haining maker of nutritional softgel products for China and other Asia Pacific markets. And second, Catalent formed a JV with ShangPharma that will provide supplies of drugs for clinical trials. Catalent is involved in drug delivery systems, including soft gels, and it also provides clinical and commercial supplies of drugs world-wide. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors